HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rice, J. Articles by Stevenson, F. K. Search for Related Content PubMed PubMed Citation Articles by Rice, J. Articles by Stevenson, F. K.

DNA Fusion Vaccines Induce Targeted Epitope-Specific CTLs against Minor Histocompatibility Antigens from a Normal or Tolerized Repertoire¹

Jason Rice^2,*, Sarah Buchan^*, Hamlata Dewchand, Elizabeth Simpson and Freda K. Stevenson^*

^* Molecular Immunology Group, Southampton University Hospitals Trust, Southampton, Hampshire, United Kingdom; and Transplantation Biology Group, Clinical Sciences Centre, Imperial College, Hammersmith Hospital, London, United Kingdom

We have designed DNA fusion vaccines able to induce high levels of epitope-specific CD8⁺ T cells, using linked CD4⁺ T cell help. Such vaccines can activate effective immunity against tumor Ags. To model performance against minor histocompatibility (H) Ags important in allogeneic hemopoietic stem cell transplantation, responses against the H2D^b-restricted Uty and Smcy male HY epitopes have been investigated. Vaccination of females induced high levels of tetramer-specific, IFN--producing CD8⁺ T cells against each epitope. Vaccines incorporating a single epitope primed effector CTL able to kill male splenocytes in vitro and in vivo, and HY^DbUty-specific vaccination accelerated rejection of syngeneic male skin grafts. Priming against either epitope established long-term memory, expandable by injection of male cells. Expanded CD8⁺ T cells remained specific for the priming HY epitope, with responses to the second suppressed. To investigate vaccine performance in a tolerized repertoire, male mice were vaccinated with the fusion constructs. Strikingly, this also generated epitope-specific IFN--producing CD8⁺ T cells with cytotoxic function. However, numbers and avidity were lower than in vaccinated females, and vaccinated males failed to reject CFSE-labeled male splenocytes in vivo. Nevertheless, these findings indicate that DNA fusion vaccines can mobilize CD8⁺ T cells against endogenous minor H Ags, even from a profoundly tolerized repertoire. In the transplantation setting, vaccination of donors could prime and expand specific T cells for in vivo transfer. For patients, vaccination could activate a potentially less tolerized repertoire against similar Ags that may be overexpressed by tumor cells, for focused immune attack.

This article has been cited by other articles:

				C. Chaise, S. L. Buchan, J. Rice, J. Marquet, H. Rouard, M. Kuentz, G. E. Vittes, V. Molinier-Frenkel, J.-P. Farcet, H. J. Stauss, et al. DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance Blood, October 1, 2008; 112(7): 2956 - 2964. [Abstract] [Full Text] [PDF]

				H. Ito, K. Ando, T. Ishikawa, T. Nakayama, M. Taniguchi, K. Saito, M. Imawari, H. Moriwaki, T. Yokochi, S. Kakumu, et al. Role of V{alpha}14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V{alpha}14+ NKT cells promotes the breakage of CTL tolerance Int. Immunol., July 1, 2008; 20(7): 869 - 879. [Abstract] [Full Text] [PDF]

				A. L. Furmanski, C. Ferreira, I. Bartok, S. Dimakou, J. Rice, F. K. Stevenson, M. M. Millrain, E. Simpson, and J. Dyson Public T Cell Receptor -Chains Are Not Advantaged during Positive Selection J. Immunol., January 15, 2008; 180(2): 1029 - 1039. [Abstract] [Full Text] [PDF]

				G. Kanter, J. Yang, A. Voloshin, S. Levy, J. R. Swartz, and R. Levy Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines Blood, April 15, 2007; 109(8): 3393 - 3399. [Abstract] [Full Text] [PDF]

				N. J. Robertson, J.-G. Chai, M. Millrain, D. Scott, F. Hashim, E. Manktelow, F. Lemonnier, E. Simpson, and J. Dyson Natural Regulation of Immunity to Minor Histocompatibility Antigens J. Immunol., March 15, 2007; 178(6): 3558 - 3565. [Abstract] [Full Text] [PDF]

				H. A. Doyle, J. Zhou, M. J. Wolff, B. P. Harvey, R. M. Roman, R. J. Gee, R. A. Koski, and M. J. Mamula Isoaspartyl Post-translational Modification Triggers Anti-tumor T and B Lymphocyte Immunity J. Biol. Chem., October 27, 2006; 281(43): 32676 - 32683. [Abstract] [Full Text] [PDF]

				M. J. Palmowski, U. Gileadi, M. Salio, A. Gallimore, M. Millrain, E. James, C. Addey, D. Scott, J. Dyson, E. Simpson, et al. Role of Immunoproteasomes in Cross-Presentation J. Immunol., July 15, 2006; 177(2): 983 - 990. [Abstract] [Full Text] [PDF]

				J. Rice, S. Dunn, K. Piper, S. L. Buchan, P. A. Moss, and F. K. Stevenson DNA Fusion Vaccines Induce Epitope-Specific Cytotoxic CD8+ T Cells against Human Leukemia-Associated Minor Histocompatibility Antigens. Cancer Res., May 15, 2006; 66(10): 5436 - 5442. [Abstract] [Full Text] [PDF]

				S. Buchan, E. Gronevik, I. Mathiesen, C. A. King, F. K. Stevenson, and J. Rice Electroporation as a "Prime/Boost" Strategy for Naked DNA Vaccination against a Tumor Antigen J. Immunol., May 15, 2005; 174(10): 6292 - 6298. [Abstract] [Full Text] [PDF]